ScienceDaily
Scientists reveal new blood pressure treatment that works when others fail
Baxdrostat is emerging as a promising breakthrough for patients with treatment-resistant hypertension, delivering an average blood pressure reduction of nearly 10 mmHg in a large global trial. The drug works by blocking a hormone responsible for excess salt and water retention — a mechanism distinct from existing therapies. For the millions who have exhausted standard options, it could meaningfully cut their risk of heart attack, stroke, and kidney disease.
Read article →